This information was published on 2022-03-28T14:33:15 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2258253 (IR 1651618) |
| (220) |
16 Feb 2022
|
| (300) |
US, 22 Sep 2021, 97039740
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the prevention and treatment of oncological diseases and disorders. |
| (540) | PANAVANCE |
| (550) | Word |
| (730) |
PANAVANCE THERAPEUTICS INC.
|
Find out more about publications on the About page.